This report contains market size and forecasts of HIV Integrase Strand Transfer Inhibitors (INSTI) in Global, including the following market information:
Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global HIV Integrase Strand Transfer Inhibitors (INSTI) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Raltegravir Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of HIV Integrase Strand Transfer Inhibitors (INSTI) include Adcock Ingram Limited, Affine Formulations Limited, Aurobindo Pharma, Biocon Limited, Bristol-Myers Squibb, Cipla, Emcure Pharmaceuticals, Flamingo Pharmaceuticals Limited and Gilead Sciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the HIV Integrase Strand Transfer Inhibitors (INSTI) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Segment Percentages, by Type, 2021 (%)
Raltegravir
Elvitegravir Combination Drugs
Dolutegravir and Its Combination Drug
Bictegravir Combination Drug
Cabotegravir
Other
Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Drug Center
Other
Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies HIV Integrase Strand Transfer Inhibitors (INSTI) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies HIV Integrase Strand Transfer Inhibitors (INSTI) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Adcock Ingram Limited
Affine Formulations Limited
Aurobindo Pharma
Biocon Limited
Bristol-Myers Squibb
Cipla
Emcure Pharmaceuticals
Flamingo Pharmaceuticals Limited
Gilead Sciences
Hetero Drugs
IPCA Laboratories
Janssen Pharmaceutica (Johnson & Johnson)
LAURUS Labs
Medisist Pharma
Merck
Mylan
Ranbaxy Pharmaceuticals
Shanghai Desano Pharmaceuticals
ViiV Healthcare (GSK)